kras mutation and glutathion Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation the Potential of Immunotherapy Kinetic and Redox Characterization of
Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv What should we know about the 'undruggable' target KRAS? MedChemExpress Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell Impact of KRAS mutation on the tumor microenvironment in colorectal cancer Targeting KRAS: from metabolic regulation to cancer treatment Molecular Cancer Springer Nature Link KRAS in Non Small Cell Lung Cancer Encyclopedia MDPI
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5





